Discover Oncology Journal Citation Rate 2026

ISSN 2730-6011 Springer Nature US

Approx. Q2 Quartile Open Access

About Discover Oncology
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Discover Oncology (DO) is an academic journal covering Cancer Immunotherapy and Biomarkers and Cancer-related molecular mechanisms research, published by Springer Nature in US, catalogued under ISSN 2730-6011. As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 1.83 (approximate Q2 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access, with an Article Processing Charge (APC) of approximately $1067 USD. OpenAlex records 5,088 works and 15,312 citations, with an h-index of 34.

Discover Oncology Citation Rate 2026 — In Context

Discover Oncology has a 2025 2-Year Citation Rate (OpenAlex) of 1.83, placing it in the approximate Q2 quartile within the Cancer Immunotherapy and Biomarkers research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

As a fully open-access publication, Discover Oncology makes all articles freely available to readers for an Article Processing Charge of approximately $1067 USD.

Researchers looking to publish in Discover Oncology should review the journal's submission tips and check the latest indexing status at the source (the Scopus Sources list, DOAJ and Web of Science); our indexing tracker shows the OpenAlex and DOAJ coverage we hold. To compare Discover Oncology against similar journals in the field, use our journal comparison tool.

Submission Tips for Discover Oncology
  • Budget $1067 for the Article Processing Charge. Check if your institution or funder covers OA fees.
  • This journal covers Cancer Immunotherapy and Biomarkers, Cancer-related molecular mechanisms research, Ferroptosis and cancer prognosis. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Discover Oncology Compares
Citation Rate vs Field Avg
-48%
Field avg: 3.49
APC vs Field Avg
-65%
Field avg: $3077

Compared against 57 journals in the same research areas.

ISSN (Print) 2730-6011
Publisher Springer Nature
Country United States
APC / Cost $1067 USD
h-index 43
Total Works 5,722
Total Citations 23,949
2-yr Mean Citedness 3.42 (OpenAlex)
DOAJ Listed
In-depth profile & metrics

Discover Oncology is published by Springer Nature and based in United States. It publishes open access with an article-processing charge of USD 1067.

In our subject taxonomy, Discover Oncology is classified under Cancer Immunotherapy and Biomarkers, Cancer-related molecular mechanisms research, Ferroptosis and cancer prognosis and Immune cells in cancer.

Discover Oncology is indexed in the DOAJ and OpenAlex. DOAJ lists the journal as open access.

OpenAlex records 5,722 works that have together drawn 23,949 citations, giving the journal an h-index of 43; its most recent citation rate stands at 1.826; OpenAlex puts its two-year mean citedness at 3.42.

Research Areas
Links
Frequently Asked Questions about Discover Oncology

Discover Oncology does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 1.826 — an open proxy for citation impact, not the licensed JCR Impact Factor.

Yes, Discover Oncology is an open access journal.

The Article Processing Charge (APC) for Discover Oncology is $1067 USD.

Discover Oncology is published by Springer Nature.

Discover Oncology appears in: OpenAlex. A listing is one signal of a legitimate journal, but it is not proof, and JournalsHub does not verify peer review. Always confirm the journal's peer-review policy, scope and editorial board before submitting.

The ISSN of Discover Oncology is 2730-6011.

Discover Oncology sits in the Q2 quartile based on its latest impact factor of 1.83, ranked across all journals in our database.
OpenAlex and DOAJ Coverage
Updated April 2026

OpenAlex and DOAJ coverage we hold for this journal. Check other databases at the source.

OpenAlex
In OpenAlex
DOAJ
Indexed OA
Predatory Check
Clean
Citation Rate
1.826
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 1.826 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex and DOAJ and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.


Works Published per Year (2015–2025)

Annual publication volume sourced from OpenAlex. Current year omitted (partial data).

Publication & citation history by year
YearWorks publishedCitations received
2025 2,542 7,231
2024 849 2,126
2023 235 965
2022 146 272
2021 65 26
2020 0 1
2018 0 1
2016 0 1
2015 0 1
Journal at a Glance
5,722
Total Works
23,949
Total Citations
43
h-index
3.42
2-Yr Mean Citedness
DOAJ Indexed APC $1690 USD

Source: OpenAlex — refreshed daily.

Top Research Topics

The areas where Discover Oncology most frequently publishes, ranked by article volume. Click a topic to see the best journals for it.

Ferroptosis and cancer prognosis
Biochemistry, Genetics and Molecular Biology
920 works
Cancer-related molecular mechanisms research
Biochemistry, Genetics and Molecular Biology
821 works
Breast Cancer Treatment Studies
Biochemistry, Genetics and Molecular Biology
550 works
350 works
341 works
Genetic Associations and Epidemiology
Biochemistry, Genetics and Molecular Biology
309 works
Research Highlights

Recently published high-impact papers in this journal:

Compare Journals

Compare Discover Oncology against similar publications in its field:

Related Journals in Your Field

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S4210213696

Get weekly updates for Cancer Immunotherapy and Biomarkers journals

Free. Monday morning. New citation rates, CFPs, updates on journals you track, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google